demonstrated that Schisandrin B inhibits NLRP3 inflammasome activation and pyroptosis through the miR-135a-5p/TRPC1/STAT3/NF-κB axis, thereby reducing airway inflammation and remodeling in asthma (135). This evidence concerns the gene NLRP3 and asthma.